Pharma Industry Calls Health Innovation a Key Investment Industry

Global health leaders and drug companies met in Geneva to talk about the future of health care.

Geneva was the center of a big global meeting. Leaders said that medical innovation should not be seen as a cost. They said it should be seen as a smart long term investment.

Experts from companies like AstraZeneca and Roche joined the discussion. They said new medicines, vaccines and health tools can help save lives and also grow the economy.

They explained that when people are healthy they miss fewer work days. This helps countries grow stronger economies.

Some leaders said governments should spend more money on prevention. They said stopping disease early can reduce hospital costs later.

Canada also announced new investments in health systems. The country plans to spend more money to improve drug research and speed up medicine approval.

European health officials said health budgets are under pressure. They said more money is going to security and defense. This is making health funding more difficult.

Experts also warned that global health systems need to be stronger. They said many countries still do not have easy access to basic medicines and care.

They added that innovation is important. But they said health systems must also reach all people. Including poor and small countries.

In the end, leaders agreed on one main idea. Health innovation is not just spending money. It is an investment in the future of people and the world.